FIGURE 1 Complex I (cI) is an NADH-ubiquinone oxidoreductase that pumps four protons into the intermembrane space (IMS) upon each NADH oxidation
Phase II at minimum, with a credible safety analysis
We are: (1) removing the HCHE measure beginning with the CY 2025 reporting period/CY 2027 program determination
There is no clinical trial data specifically studying this approach, but some prescribers report anecdotally that patients maintain better long-term responses with periodic dose reductions
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects
Clean your hands thoroughly and set up all components on a clean, organized surface